Phase Ib/II Clinical Trial of Pembrolizumab With Bevacizumab for Metastatic Renal Cell Carcinoma: BTCRC-GU14-003

Arkadiusz Z. Dudek,Li C. Liu,Shilpa Gupta,Theodore F. Logan,Eric A. Singer,Monika Joshi,Yousef Zakharia,Joshua M. Lang,James K. Schwarz,Anas Al-Janadi,Ajjai Alva

Phase Ib/II Clinical Trial of Pembrolizumab With Bevacizumab for Metastatic Renal Cell Carcinoma: BTCRC-GU14-003

2020

Arkadiusz Z. Dudek
Li C. Liu
Shilpa Gupta
Theodore F. Logan
Eric A. Singer
Monika Joshi
Yousef Zakharia
Joshua M. Lang
James K. Schwarz
Anas Al-Janadi
Ajjai Alva

PURPOSEWe hypothesized that bevacizumab will potentiate activity of pembrolizumab. We conducted a phase Ib/II, single-arm, multisite clinical trial of the combination in metastatic renal cell carci...

Keywords:

Clinical trial
Pathology
Bevacizumab
Oncology
Renal cell carcinoma
Medicine
Internal medicine
Cell
Pembrolizumab

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations